UPDATE 2-France's Sanofi to buy biotech firm Synthorx for $2.5 bln
December 09, 2019 at 05:22 AM EST
France's Sanofi on Monday agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion as it steps up a push in the lucrative field of cancer drugs under its new chief executive.
